Two Sigma Investments’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-102
| Closed | -$7.73K | – | 3336 |
|
2024
Q1 | $7.73K | Sell |
102
-95
| -48% | -$7.2K | ﹤0.01% | 2885 |
|
2023
Q4 | $35.1K | Buy |
+197
| New | +$35.1K | ﹤0.01% | 2934 |
|
2022
Q4 | – | Sell |
-19
| Closed | -$76K | – | 3073 |
|
2022
Q3 | $76K | Sell |
19
-109
| -85% | -$436K | ﹤0.01% | 2218 |
|
2022
Q2 | $333K | Sell |
128
-134
| -51% | -$349K | ﹤0.01% | 1924 |
|
2022
Q1 | $844K | Sell |
262
-64
| -20% | -$206K | ﹤0.01% | 1749 |
|
2021
Q4 | $2.04M | Buy |
326
+71
| +28% | +$444K | ﹤0.01% | 1310 |
|
2021
Q3 | $2.36M | Sell |
255
-215
| -46% | -$1.99M | 0.01% | 1269 |
|
2021
Q2 | $4.76M | Buy |
+470
| New | +$4.76M | 0.01% | 945 |
|